Intellia Therapeutics Inc...

NASDAQ: NTLA · Real-Time Price · USD
10.99
0.09 (0.83%)
At close: Aug 15, 2025, 3:59 PM
11.01
0.18%
After-hours: Aug 15, 2025, 07:57 PM EDT

Intellia Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.22 -5.62 -5.66 -31.29
PEG Ratio
0.71 0.47 -0.09 -0.54
PS Ratio
19.91 74.61 51.53 253.61
PB Ratio
1.32 2.58 2.17 8.06
P/FCF Ratio
-3.25 -6.63 -6.86 -35.25
P/OCF Ratio
-3.3 -6.87 -8.06 -37.25
OCF/S Ratio
-6.03 -10.86 -6.39 -6.81
Debt / Equity Ratio
0.24 0.11 0.11 0.07
Quick Ratio
5.77 8.67 10.16 6.11
Current Ratio
5.77 8.67 9.61 6.11
Asset Turnover
0.05 0.03 0.03 0.03
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.6 -0.46 -0.38 -0.26
Return on Assets
-0.44 -0.37 -0.31 -0.21
Return on Invested Capital
-0.49 -0.43 -0.33 -0.22
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.82 0.75 0.85 0.79
Net Profit Margin
-8.97 -13.27 -9.1 -8.1
Pretax Profit Margin
-8.97 -13.27 -9.1 -8.1
Operating Profit Margin
-9.23 -14.21 -8.79 -8.1
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-9.05 -13.96 -8.65 -7.9